3billion Alternatives & Competitors
12 companies similar to 3billion — Your One Answer Genetic testing for rare diseases made more efficient and more...
Companies similar to 3billion
Congenica
Driving Precision Medicine
Cambridge, United Kingdom
Macrogen Europe
Committed to Sequencing Excellence
Amsterdam, The Netherland...
Fabric Genomics
AI‑Driven Clinical Insights for Genomic Data
Oakland, United States
SciGenom Labs
Leveraging science of the genome.
San Francisco, United Sta...
Track all 3billion competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Personal Genome Diagnostics
Leading the way in patient-specific cancer genome analysis with groundbreaking technologie...
Bioarray Genetic Diagnosis
The one-stop Lab for Reproductive & Medical Genetics
Elche, Spain
Strand Life Sciences
Personalized Genomics For A Healthier Future
India
Testmate Health
Testmate is pioneering the next generation of low-cost tests, starting with sexual health...
Lausanne, Switzerland
EMPE Diagnostics
Confirmatory precision diagnostics for tuberculosis (MDR/XDR-TB) within 3 h even at resour...
Solna, Sweden
HeRui BioMed
Offering comprehensive diagnostic services from early detection of inflammatory bowel dise...
Sampling Human
Single cell analysis at massive scale.
Berkeley, United States
About 3billion
3billion, founded in 2016, is revolutionizing the realm of genetic testing for rare diseases by leveraging AI-powered genomics. Headquartered in South Korea, this company is on a mission to make rare disease diagnosis faster, more accurate, and accessible on a global scale. With over 80,000 patients tested in collabora...
Diagnostic Gene Testing, Boosted Exome Analysis, Genome Sequencing, AI Variant Prioritization, Genomic Screenings (3B-NEO), Daily Data Updates, Gene Coverage Browser
Patients with Rare Diseases, Healthcare Providers, Medical Geneticists, Diagnostic Laboratories, Pharmaceutical Partners
AI-powered Genomics, Rare Disease Diagnostics, Genetic Testing, Bioinformatics, Genome Interpretation, WGS (Whole Genome Sequencing), WES (Whole Exome Sequencing), Diagnostic Reanalysis, Medical Collaboration, Genetic Services, Genomics Innovation, Healthcare Accessibility
B2B, SaaS, B2B2C
Product Sales, Tiered Pricing, Licensing
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches 3billion and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at 3billion on 15 Jun 2026. The 12 companies listed here were last checked between 26 Jul 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
